Fujifilm Systems Integration Selects caresyntax for OR Integration

Today FUJIFILM Medical Systems announced that the company has selected caresyntax, a pioneering developer in surgical automation, analytics software, as the supplier of Fujifilm Systems Integration using caresyntax’s proprietary operating room (OR) integration and workflow automation intelligence.

As the healthcare industry continues to respond to today’s uncertainties, Fujifilm trusts this new partnership to aid hospital operations, improve workflow efficiencies of the interventional space, and meet patient demand surges as deferred procedures are rescheduled.

“As the only vendor that offers endoscopic imaging as well as modality solutions and enterprise-wide IT products—launching the Fujifilm Systems Integration business will allow Fujifilm to capture the full clinical value chain,” says Devon Bream, MPH, FACHE, Global Vice President Endoscopy, General Manager Systems Integration, FUJIFILM Medical Systems U.S.A., Inc. “We selected caresyntax as our supplier because the team has a demonstrated history in developing data-driven integration that provides the total visibility to achieve increased workflow efficiency, patient safety, and surgical performance.”

Together Fujifilm and caresyntax will develop a systems integration solution designed specifically for image and data integration in the operating room (OR/Hybrid OR) and endoscopy suite that will connect Fujifilm’s medical image capture products and Synapse brand viewing, storage, and analytics technologies.

“Fujifilm’s vision of closing the loop between its powerful clinical informatics ecosystem and its trusted offerings at the point of care will be a resounding success that will create value for caregivers and patients,” says Dennis Kogan, Co-Founder and CEO, caresyntax. “caresyntax is excited to leverage our robust surgical automation and analytics platform to support Fujifilm in this endeavor. We strongly believe that data-driven collaborations with health systems, medical device companies, and insurers are key to managing surgical risk and promoting smarter, safer surgery; and are proud to partner with Fujifilm in pursuit of this common goal.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

LumiGuide, powered by Fiber Optic RealShape (FORS) technology, enables doctors to navigate through blood vessels using light, instead of X- ray. “[It’s] one of the most exciting changes that we’ve seen with imaging certainly throughout my career,” said Andres Schanzer, Vascular Surgeon, at UMass Memorial Medical Center, Worcester, MA, USA.
Carestream Health notes twenty-seven of the patents were awarded by the U.S. Patent and Trademark Office; an additional 43 patents were received in European and Asian countries.
According to an Insightec study, patients experienced significant reductions in upper limb tremor, tremor-related disability, and quality of life. The most common intraprocedural adverse events included dizziness, headache, nausea, and vomiting, which all resolved. Post-procedural adverse events included paraesthesia and gait disturbance, which were often transient or resolved within 12 months.
Chris Landon, Business Leader Image Guided Therapy Devices at Philips: “IVUS is a technology that has demonstrated an ability to both support safer procedures for patients and procedural staff alike including reductions in radiation exposure. As the global leader in IVUS solutions, we are grateful for the rigorous multidisciplinary approach to developing expert consensus on the value of IVUS and we look forward to working with all stakeholders to standardize the use of IVUS and reduce the barriers preventing utilization.”
"We are delighted to see our 3D solution CE-marked and available on the European market," says Ulrik Harrysson, CEO at SyntheticMR AB. "SyMRI 3D represents the next generation of quantitative MRI, offering unprecedented resolution and accuracy in brain imaging, revolutionizing the landscape of medical diagnostics."

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version